I think it's only for acute cases, not chronic. Maybe you are within the timeframe? I called Silverstein and they said I had tinnitus too long to be in trial.An update on those in the CA area, Otonomy is now recruiting in Los Angeles and San Diego for their phase 1/2 trial of OTO-313 for the treatment of tinnitus.
United States, California
House Clinic Recruiting
Los Angeles, California, United States, 90057
Contact: Shanel Hill shill@hei.org
California Head & Neck Specialists Recruiting
San Diego, California, United States, 92121
Contact: Tricia Doughty 858-909-0770 tricia.doughty@calhns.com
I myself am thinking of giving this a shot.
An update on those in the CA area, Otonomy is now recruiting in Los Angeles and San Diego for their phase 1/2 trial of OTO-313 for the treatment of tinnitus.
United States, California
House Clinic Recruiting
Los Angeles, California, United States, 90057
Contact: Shanel Hill shill@hei.org
I myself am thinking of giving this a shot.
Aww shucks, I'm sorry to hear that. I really feel like this acute and chronic stuff makes not much sense. If the mechanisms are the same, it shouldn't make much of a difference.I think it's only for acute cases, not chronic. Maybe you are within the timeframe? I called Silverstein and they said I had tinnitus too long to be in trial.
Hahaha good gif.View attachment 32289
Wow in LA too!? I might give it a shot as well since LA is about an hour drive from where i live.
Surely you know of the theory where longer term tinnitus gets stuck in the brain and becomes a brain problem instead of an inner ear problem. In chronic cases you need a pill from Dr. Tzounopoulos or such.I really feel like this acute and chronic stuff makes not much sense. If the mechanisms are the same, it shouldn't make much of a difference.
I think it's a brain problem to begin with. Sure it starts with an ear problem, but pretty much as soon as you hear the ringing you best believe that's the brain making the sound.Surely you know of the theory where longer term tinnitus gets stuck in the brain and becomes a brain problem instead of an inner ear problem. In chronic cases you need a pill from Dr. Tzounopoulos or such.
Is Silverstein in on the trial?I think it's only for acute cases, not chronic. Maybe you are within the timeframe? I called Silverstein and they said I had tinnitus too long to be in trial.
Please stop repeating this nonsense. I'm begging you.gets stuck in the brain and becomes a brain problem
This has not been proven.you best believe that's the brain making the sound.
Yeah they are listed. The contact person called me back. Judging by their stock price it probably doesn't work. Worth a try for those eligible though. Only half a chance of getting the real thing I suppose.Is Silverstein in on the trial?
Stock price is not at all a way to judge if a drug works. Small cap biotechs are famously easy to manipulate for large capital firms.Yeah they are listed. The contact person called me back. Judging by their stock price it probably doesn't work. Worth a try for those eligable though. Only half a chance of getting the real thing I suppose.
You know a lot more than me about evaluating stocks, that's for sure. I just know OTIC's formulation was similar to EAR's, only more potent. A stock selling off from about $20 to $2 can't be a good sign regarding investor's confidence. And it's remained low for a long time with very little volatility.Stock price is not at all a way to judge if a drug works
The sell off was for their Meniere's drug (sustained release intratympanic steroid) not meeting clinical endpoints. However, I believe it was later shown that the drug worked really well in earlier phases and doctors were telling people this to recruit them and inadvertently making the placebo more effective for vertigo in the process. They have restarted a phase 3 with new FDA guidance after this if I understand correctly.You know a lot more than me about evaluating stocks, that's for sure. I just know OTIC's formulation was similar to EAR's, only more potent. A stock selling off from about $20 to $2 can't be a good sign regarding investor's confidence. And it's remained low for a long time with very little volatility.
Of course I hope OTO-313 works on tinnitus.
Damn.. I seriously think they take that so seriously for no reason, @JohnAdams all research, pretty much from every direction, is pointing at the brain making the sound. Yes it's in response to damage in the ear, but it's not the ear making the noise, it's the brain.
I don't believe it. I'm sure they can see the brain lighting up in the auditory cortex, but that just means it's getting a signal, I think. I surely don't know for a fact, but it's my absolute opinion.Damn.. I seriously think they take that so seriously for no reason, @JohnAdams all research, pretty much from every direction, is pointing at the brain making the sound. Yes it's in response to damage in the ear, but it's not the ear making the noise, it's the brain.
Isn't the current hypothesis that the brain creates a sound in response to missing input? Perhaps it's both?I don't believe it. I'm sure they can see the brain lighting up in the auditory cortex, but that just means it's getting a signal, I think. I surely don't know for a fact, but it's my absolute opinion.
Lie.
It seems they just have to take your word for it.How are they to know if you say it's only been a few months?
I think if you restore hearing or if you get the nerve excitation to stop, it can stop.Isn't the current hypothesis that the brain creates a sound in response to missing input? Perhaps it's both?
You restore hearing though, the noise should stop.
Piggybacking on FGG's comment, I work with a guy whose hobby has been stocks for many years and he's had some success. His advice to me is "you always wait until just before they release the Phase 3 trial data to buy." The idea being that if Phase 3 proves the product will work, people will start buying the stock like crazy. But you don't want to buy when they are phase 1/2 because "your money just stagnates."Yeah they are listed. The contact person called me back. Judging by their stock price it probably doesn't work. Worth a try for those eligible though. Only half a chance of getting the real thing I suppose.
Neuroscience has come a long way, we used to think the brain never spawned new neurons after birth, today, that's entirely flipped on its head on a 180 spin. The brain is extremely plastic, mindfulness meditation has been proven to enlarge the hippocampus and frontal cortex, and shrink the amygdala.I think if you restore hearing or if you get the nerve excitation to stop, it can stop.
I do think there is a component of it that is in the brain (i.e. from what I understand, people who have had their entire cochleas removed can still have tinnitus) BUT restoring normal signal should stop the "phantom" sounds since they are compensatory. I highly doubt it's just "stuck" there since the brain is so plastic anyway.
Used to be a hobby of mine, too, when i still had a career and money to risk.Piggybacking on FGG's comment, I work with a guy whose hobby has been stocks for many years and he's had some success. His advice to me is "you always wait until just before they release the Phase 3 trial data to buy." The idea being that if Phase 3 proves the product will work, people will start buying the stock like crazy. But you don't want to buy when they are phase 1/2 because "your money just stagnates."
It seems that companies who are publicly traded don't get rewarded with money until after they've proven their product will work, which on the one hand makes sense and is good incentive to come out with a good product. On the other hand, it could (and this is just me speculating) take longer to complete their work because funding isn't as generous earlier on.
Concerning the fact that they are limiting their early Phase trial participants to acute sufferers, I kinda feel like that's a move to have really good numbers up front, since tinnitus can diminish on it's own in the first few months. So you maybe have some people actually improve because of their drug but others maybe get better regardless. Their 2017 reports on their Otividex product were not promising and they had to go back and rework it. This trial could have some built in damage control so they don't lose more investor faith. Not saying it won't work or they are dishonest. Just a theory.
Don't you think that on hearing regeneration it will be a bit the same type of lottery?